# Boston Scientific Corporation (BSX) — Q4-2020 Earnings Results

**Report date:** 2021-02-03 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q4-2020

## Post-Earnings Brief

### Headline

Boston Scientific Misses on EPS, Stock Up 2.21%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.23 | N/A | -26.05% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management acknowledged the difficulties faced during the quarter but maintained a positive outlook for future growth. They emphasized their commitment to innovation and market expansion.

**Key quotes:**

> Management highlighted ongoing challenges but expressed confidence in long-term growth.

> They noted improvements in certain product lines despite the current environment.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Boston Scientific's earnings report showed a significant miss on EPS, which may raise concerns among investors about profitability. However, the stock reacted positively, increasing by 2.21%, likely due to management's optimistic tone about long-term growth and product improvements. Investors may be encouraged by the company's focus on innovation despite current challenges.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q4-2020_